Known Cancer-Associated Genetic Sequences are More Conserved in Long-Lived Species
Key claim: Cancer-associated genetic sequences are more conserved in long-lived species than in short-lived ones, with distinct epigenetic modification patterns at those loci that may help explain reduced cancer risk.
Abstract
Suppression of cancer is a necessary component of species longevity, and finding out how exactly cancer incidence is in some cases dramatically reduced is one of the primary goals for the field of comparative biology. Here, researchers survey known cancer-associated sequences across the genomes of long-lived and short-lived species, and see that sequences are more conserved in long-lived species. Patterns of epigenetic modifications to the genome at these locations also exhibit differences in long-lived species. Thus one component of reduced cancer risk in these species involves specific sequence differences in oncogenes and related genes, and different expression of oncogenes in circumstances relevant to induction of cancer. Recently, accumulated evidence has shown that longer-lived species, such as naked mole rats, elephants, and some bat species display […]
Why this matters
Peto’s paradox — why large, long-lived species aren’t overrun by cancer — has mostly been explained by tumor-suppressor gene duplications (TP53 in elephants), altered interferon responses, or cell-competition mechanisms. A comparative-genomics layer showing that cancer-associated sequences themselves are more conserved in long-lived species, and carry distinct local epigenetic marks, shifts part of the explanation from ‘extra copies of suppressors’ toward ‘tighter sequence + regulatory maintenance at oncogenic loci.’ Whether this generalizes or translates to human cancer-risk modulation is entirely open; the finding is a species-comparison signal, not an intervention pathway.